Literature DB >> 16092311

Serum magnesium, phosphate and calcium in Nigerian children with sickle cell disease.

O O Oladipo1, E O Temiye, V C Ezeaka, P Obomanu.   

Abstract

BACKGROUND: Biochemical abnormalities have been associated with sickle cell disease. Studies on phosphorus and magnesium in sickle cell disease have been conflicting. There is paucity of information on the role of these ions in the pathogenesis and management of sickle cell disease. This study was set out to determine the serum levels of magnesium, phosphorus and calcium in Nigerian children with sickle cell disease. STUDY
DESIGN: A case-control study carried out on children with HbSS genotype (cases) and age-matched controls with HbAA. Serum magnesium, calcium, phosphorus and albumin were measured using colorimetric methods.
RESULTS: Eighty-six subjects and forty-five controls were studied. The mean serum magnesium was 0.99mmol/L (0.02) and 0.98mmol/L (0.02) in the cases and controls respectively. The difference was not significant. Mean serum calcium was significantly lower in the cases [2.1mmol/L (0.3)] compared with the controls [2.3mmol/ L (0.15)]; p<0.01. Serum phosphorus was significantly higher in the cases than in the controls [2.2mmol/L (0.7) versus (1.5mmol/L (0.6); p<0.001]. There was no statistical difference in the albumin binding of calcium in both groups. A positive correlation existed between serum phosphorus and magnesium and also between serum calcium and magnesium in the cases group but no correlation between these parameters and age was found.
CONCLUSION: Children with sickle cell anaemia in this study had normo-magnesaemia, hyperphosphataemia and hypocalcaemia. Further studies on changes in intracellular concentrations of these ions in children with sickle cell disease are required. Such findings could be useful in designing better management in individuals with this abnormality.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16092311     DOI: 10.4314/wajm.v24i2.28180

Source DB:  PubMed          Journal:  West Afr J Med        ISSN: 0189-160X


  10 in total

1.  Biochemical indicator of sickle cell disease: preliminary report from India.

Authors:  S Pandey; A Sharma; S Dahia; V Shah; V Sharma; R M Mishra; Sw Pandey; R Saxena
Journal:  Indian J Clin Biochem       Date:  2011-09-25

Review 2.  Zinc, Magnesium, and Copper Levels in Patients with Sickle Cell Disease: A Systematic Review and Meta-analysis.

Authors:  Ibrahim H Elkhidir; Shahd S Ali; Waad K Ali; Hind R Madani; Rawya A Basheir; Rayan M Altayeb; Rayan H S Shazali; Safaa Fadlelmoula; Wisal M Eltayeb; Zeina I Omar; Mahmoud Elnil; Sagad O O Mohamed
Journal:  Avicenna J Med       Date:  2022-07-02

3.  Magnesium for treating sickle cell disease.

Authors:  Nan Nitra Than; Htoo Htoo Kyaw Soe; Senthil K Palaniappan; Adinegara Bl Abas; Lucia De Franceschi
Journal:  Cochrane Database Syst Rev       Date:  2019-09-09

4.  The Role of Nutrition in Sickle Cell Disease.

Authors:  H I Hyacinth; B E Gee; J M Hibbert
Journal:  Nutr Metab Insights       Date:  2010-01-01

5.  Evaluation of creatine kinase activity and inorganic phosphate concentration in adult nigerian homozygous and heterozygous hemoglobin phenotypes.

Authors:  Ee Nnadi; Po Manafa; Ec Okocha; Go Chukwuma; Jc Aneke
Journal:  Ann Med Health Sci Res       Date:  2014-09

6.  Total Serum Magnesium Levels and Calcium-To-Magnesium Ratio in Sickle Cell Disease.

Authors:  Charles Antwi-Boasiako; Yaw A Kusi-Mensah; Charles Hayfron-Benjamin; Robert Aryee; Gifty Boatemaah Dankwah; Lim Abla Kwawukume; Ebenezer Owusu Darkwa
Journal:  Medicina (Kaunas)       Date:  2019-08-29       Impact factor: 2.430

7.  Nutritional perspectives on sickle cell disease in Africa: a systematic review.

Authors:  Eunice Berko Nartey; Jonathan Spector; Seth Adu-Afarwuah; Catherine L Jones; Alan Jackson; Agartha Ohemeng; Rajiv Shah; Alice Koryo-Dabrah; Amma Benneh-Akwasi Kuma; Hyacinth I Hyacinth; Matilda Steiner-Asiedu
Journal:  BMC Nutr       Date:  2021-03-18

8.  Comparative Effectiveness of a Six-Week Treatment Course of Vitamin D2 and D3 in Children With Sickle Cell Anemia in Steady State With Hypovitaminosis D: A Randomized Clinical Trial.

Authors:  Motunrayo Oluwabukola Adekunle; Adeyemi Oluwaseun Dada; Fidelis Olisamedua Njokanma; Adaobi Uzoamaka Solarin; Barakat Adeola Animasahun; Moriam Omolola Lamina
Journal:  J Hematol       Date:  2021-06-16

Review 9.  Phytomedicines and nutraceuticals: alternative therapeutics for sickle cell anemia.

Authors:  Ngozi Awa Imaga
Journal:  ScientificWorldJournal       Date:  2013-02-14

Review 10.  Precipitating factors and targeted therapies in combating the perils of sickle cell disease--- A special nutritional consideration.

Authors:  Shahida A Khan; Ghazi Damanhouri; Ashraf Ali; Sarah A Khan; Aziz Khan; Ahmed Bakillah; Samy Marouf; Ghazi Al Harbi; Saeed H Halawani; Ahmad Makki
Journal:  Nutr Metab (Lond)       Date:  2016-08-08       Impact factor: 4.169

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.